167 related articles for article (PubMed ID: 27254056)
1. Infantile Bullous Pemphigoid Following Vaccination.
Bisherwal K; Pandhi D; Singal A; Sharma S
Indian Pediatr; 2016 May; 53(5):425-6. PubMed ID: 27254056
[TBL] [Abstract][Full Text] [Related]
2. Infantile bullous pemphigoid following vaccination.
Guerra L; Pedicelli C; Fania L; De Luca N; Condorelli AG; Mazzanti C; Di Zenzo G
Eur J Dermatol; 2018 Oct; 28(5):708-710. PubMed ID: 30325317
[No Abstract] [Full Text] [Related]
3. Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review.
de la Fuente S; Hernández-Martín Á; de Lucas R; González-Enseñat MA; Vicente A; Colmenero I; González-Beato M; Suñol M; Torrelo A
Pediatr Dermatol; 2013; 30(6):741-4. PubMed ID: 24125034
[TBL] [Abstract][Full Text] [Related]
4. [Infantile bullous pemphigoid developing after hexavalent, meningococcal and pneumococcal vaccinations].
Valdivielso-Ramos M; Velázquez D; Tortoledo A; Hernanz JM
An Pediatr (Barc); 2011 Sep; 75(3):199-202. PubMed ID: 21676664
[TBL] [Abstract][Full Text] [Related]
5. Postvaccinal, corticosteroid-resistant bullous pemphigoid in infancy: treatment with intravenous immunoglobulin.
Ister M; Pouessel G; Ythier H; Catteau B; Carpentier O
Pediatr Dermatol; 2014; 31(4):e94-5. PubMed ID: 24916151
[TBL] [Abstract][Full Text] [Related]
6. Childhood bullous pemphigoid developed after the first vaccination.
Baykal C; Okan G; Sarica R
J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):348-50. PubMed ID: 11174412
[TBL] [Abstract][Full Text] [Related]
7. Infantile bullous pemphigoid successfully treated with combined pulse corticosteroids and high-dose IVIG.
Wawrzycki B; Krasowska D; Pietrzak A; Szumilo J; Blazowski L; Pietraszek-Mamcarz J; Lotti T
Dermatol Ther; 2018 Sep; 31(5):e12635. PubMed ID: 30216603
[TBL] [Abstract][Full Text] [Related]
8. Childhood bullous pemphigoid treated by i.v. immunoglobulin.
Xiao T; Li B; Wang YK; He CD; Chen HD
J Dermatol; 2007 Sep; 34(9):650-3. PubMed ID: 17727369
[TBL] [Abstract][Full Text] [Related]
9. [Infantile bullous pemphigoid].
Barreau M; Stefan A; Brouard J; Leconte C; Morice C; Comoz F; Verneuil L
Ann Dermatol Venereol; 2012; 139(8-9):555-8. PubMed ID: 22963966
[TBL] [Abstract][Full Text] [Related]
10. Childhood bullous pemphigoid following hepatitis B immunization.
Erbagci Z
J Dermatol; 2002 Dec; 29(12):781-5. PubMed ID: 12532044
[TBL] [Abstract][Full Text] [Related]
11. Infantile bullous pemphigoid after meningococcal B vaccine.
Pérez-Feal P; Pita da Veiga G; Sánchez-Aguilar D; Aliste C; Vázquez-Veiga H; Vázquez-Osorio I
Int J Dermatol; 2021 Sep; 60(9):1172-1173. PubMed ID: 33527376
[No Abstract] [Full Text] [Related]
12. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
Szenborn L; Czajka H; Brzostek J; Konior R; Caubet M; Ulianov L; Leyssen M
Pediatr Infect Dis J; 2013 Jul; 32(7):777-85. PubMed ID: 23838777
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J; Dal-Ré R; Díez-Delgado J; Marés J; Casanovas JM; García-Corbeira P; De Frutos E; Van Esso D; Verdaguer J; De la Flor J; Moraga F; Boceta R; García-Martínez JA
Vaccine; 2003 Sep; 21(25-26):3593-600. PubMed ID: 12922087
[TBL] [Abstract][Full Text] [Related]
15. Risk of immune hemolytic anemia in children following immunization.
Naleway AL; Belongia EA; Donahue JG; Kieke BA; Glanz JM;
Vaccine; 2009 Dec; 27(52):7394-7. PubMed ID: 19766577
[TBL] [Abstract][Full Text] [Related]
16. Sensorimotor polyneuropathy after hexavalent vaccination.
Gorczyca D; Schwirten U
Scand J Infect Dis; 2014 Jan; 46(1):66-8. PubMed ID: 24053264
[TBL] [Abstract][Full Text] [Related]
17. Bullous pemphigoid in infant post vaccination: Myth or reality?
Neri I; Greco A; Bassi A; Orgaz-Molina J; Balestri R; Oranges T; Patrizi A; de Martino M
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):295-9. PubMed ID: 26684642
[TBL] [Abstract][Full Text] [Related]
18. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T; Rivera L; Korhonen T; Ahonen A; Cheuvart B; Hezareh M; Janssens W; Mesaros N
Hum Vaccin Immunother; 2017 Jul; 13(7):1505-1515. PubMed ID: 28340322
[TBL] [Abstract][Full Text] [Related]
20. A Case of Bullous Pemphigoid in a Five-Month-Old Female: A Rare Presentation.
Ahmed M; AlFalasi A; AlQaydi FM
Cureus; 2023 Aug; 15(8):e42871. PubMed ID: 37664259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
